Description
A pan-NADPH oxidase inhibitor; pre-incubation of rat smooth muscle cells abolishes PDGF induced chemotaxis (IC50 = 10 µM); increases glucose-stimulated insulin secretion of rat pancreatic islets by 70%; reduces production of ROS in vitro and in vivo; is neuroprotective in murine stroke models
Formal name: 7-(2-benzoxazolylthio)-3-(phenylmethyl)-3H-1,2,3-triazolo[4,5-d]pyrimidine
Synonyms:
Molecular weight: 360.4
CAS: 722456-31-7
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Cardiovascular System|Vasculature|Smooth Muscle Cells||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Neuroscience||Research Area|Oxidative Stress & Reactive Species|Antioxidant Activity||Research Area|Oxidative Stress & Reactive Species|Reactive Oxygen